Investview (“INVU”) Reports Strong Financial Results for the Nine Months Ended December 31, 2021 Net Revenue increased 89% to $72.2 million in 9 months ended December 31, 2021 compared to $38.3 million for the 12 months ended March 31, 2021Total assets increased 163% to $51.5 million at December...

International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018 Increases in Revenues and Profit MarginsNet Income Realized for the Quarter CARLSBAD, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO)...